Arcus Biosciences, Inc. (RCUS)
22.96
+1.12
(+5.13%)
USD |
NYSE |
Apr 02, 16:00
22.98
+0.02
(+0.09%)
After-Hours: 20:00
Arcus Biosciences Research and Development Expense (TTM) : 523.00M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Merck & Co., Inc. | 12.71B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| TG Therapeutics, Inc. | 160.22M |